Marginal biotin deficiency can be induced experimentally in humans using a cost-effective outpatient design

Journal of Nutrition

Volumn 142, Issue 1, 2012, Pages 22-26

  Stratton, Shawna L ^a   Henrich, Cindy L ^a,b   Matthews, Nell I ^a   Bogusiewicz, Anna ^a   Dawson, Amanda M ^b   Horvath, Thomas D ^a   Owen, Suzanne N ^a,b   Boysen, Gunnar ^c   Moran, Jeffery H ^a,b   Mock, Donald M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYISOVALERIC ACID; 3 HYDROXYISOVALERYL CARNITINE; AVIDIN; BIOTIN; CARNITINE DERIVATIVE; EGG WHITE; ISOVALERIC ACID; LEUCINE; PROPIONYL COENZYME A CARBOXYLASE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BODY WEIGHT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIET; DIETARY INTAKE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE; MALE; MARGINAL BIOTIN DEFICIENCY; MOUSE; NONHUMAN; NORMAL HUMAN; OUTPATIENT CARE; URINARY EXCRETION; VITAMIN DEFICIENCY;

ANIMALS; BIOTIN; COST-BENEFIT ANALYSIS; DEFICIENCY DISEASES; FEMALE; HUMANS; MALE; MICE; OUTPATIENTS;

EID: 84855533982     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.151621     Document Type: Article

References (31)

1. Mock DM. Biotin. In: Zempleni J, Rucker RB, McCormick DB, Suttie JW, editors. Handbook of vitamins. 4th ed. Boca Raton (FL): CRC Press; 2007. p. 361-84.
2. Zempleni J. Biotin. In: Bowman BB, Russell RM, editors. Present knowledge in nutrition. 8th ed. Washington, DC: International Life Sciences Institutes-Nutrition Foundation; 2001.
3. Pacheco-Alvarez D, Solorzano-Vargas RS, Del Rio AL. Biotin in metabolism and its relationship to human disease. Arch Med Res. 2002;33:439-47.
4. Zempleni J, Mock D. Marginal biotin deficiency is teratogenic. Proc Soc Exp Biol Med. 2000;223:14-21.
5. Watanabe T, Endo A. Teratogenic effects of maternal biotin deficiency in mouse embryos examined at midgestation. Teratology. 1990;42:295-300.
6. Watanabe T, Endo A. Biotin deficiency per se is teratogenic in mice. J Nutr. 1991;121:101-4.
7. Mock DM, Mock NI, Stewart CW, LaBorde JB, Hansen DK. Marginal biotin deficiency is teratogenic in ICR mice. J Nutr. 2003;133:2519-25.
8. Watanabe T, Dakshinamurti K, Persaud TVN. Biotin influences palatal development of mouse embryos in organ culture. J Nutr. 1995; 125:2114-21.
9. Said HM. Biotin bioavailability and estimated average requirement: why bother? Am J Clin Nutr. 1999;69:352-3.
10. Said HM. Biotin: the forgotten vitamin. Am J Clin Nutr. 2002;75:179-80.
11. Lamers Y, Coats B, Ralat M, Quinlivan EP, Stacpoole PW, Gregory JF III. Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women. J Nutr. 2011;141:835-42.
12. Sydenstricker VP, Singal SA, Briggs AP, DeVaughn NM. Preliminary observations on "Egg white injury" in man and its cure with a biotin concentrate. Science. 1942;95:176-7.
13. Mock NI, Malik MI, Stumbo PJ, Bishop WP, Mock DM. Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased status in experimental biotin deficiency. Am J Clin Nutr. 1997;65:951-8.
14. Mock DM, Henrich CL, Carnell N, Mock NI. Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge. Am J Clin Nutr. 2002;76:1061-8.
15. Vlasova TI, Stratton SL, Wells AM, Mock NI, Mock DM. Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood. J Nutr. 2005;135:42-7.
16. Mock DM, Langford G, Dubois D, Criscimagna N, Horowitz P. A fluorometric assay for the biotin-avidin interaction based on displacement of the fluorescent probe 2-anilinonaphthalene-6-sulfonic acid. Anal Biochem. 1985;151:178-81.
17. Mock NI, Mock DM. Biotin deficiency in rats: disturbances of leucine metabolism are detectable early. J Nutr. 1992;122:1493-9.
18. Sealey WM, Teague AM, Stratton SL, Mock DM. Smoking accelerates biotin catabolism in women. Am J Clin Nutr. 2004;80:932-5.
19. Mock DM, Dyken ME. Biotin catabolism is accelerated in adults receiving long-term therapy with anticonvulsants. Neurology. 1997; 49:1444-7.
20. Krause K-H, Berlit P, Bonjour J-P. Impaired biotin status in anticonvulsant therapy. Ann Neurol. 1982;12:485-6.
21. Krause K-H, Berlit P, Bonjour J-P. Vitamin status in patients on chronic anticonvulsant therapy. Int J Vitam Nutr Res. 1982;52:375-85.
22. Mock D, Henrich CL, Carnell N, Mock NI, Swift L. Lymphocyte propionyl-CoA carboxylase and accumulation of odd-chain fatty acid in plasma and erythrocytes are useful indicators of marginal biotin deficiency. J Nutr Biochem. 2002;13:462-70.
23. Mock DM, Horvath T, Stratton S, Bogusiewicz A, Moran J. Urinary excretion of 3-hydroxyisovaleryl carnitine (3HIAC) in response to a leucine load increases in marginal biotin deficiency. J Nutr. 2011; 141:1925-30.
24. Horvath TD, Stratton SL, Bogusiewicz A, Pack L, Moran J, Mock DM. Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans. Anal Chem. 2010;82:4140-4.
25. Stratton SL, Horvath TD, Bogusiewicz A, Matthews NI, Henrich CL, Spencer HJ, Moran JH, Mock DM. Plasma concentration of 3- hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. Am J Clin Nutr. 2010;92:1399-405.
26. Mock DM. Determinations of biotin in biological fluids. In: Mc- Cormick DB, Suttie JW, Wagner C, editors. Methods in enzymology. New York: Academic Press; 1997. p. 265-75.
27. Horvath TD, Matthews NI, Stratton SL, Mock DM, Boysen G. Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin deficient humans by UPLC-MS/MS. Anal Bioanal Chem. 2011;410:2805-10.
28. Horvath TD, Stratton SL, Bogusiewicz A, Owen SO, Mock DM, Moran JH. Quantitativemeasurement of urinary excretion of 3-hydroxyisovaleryl carnitine by LC-MS/MS as an indicator of biotin status in humans. Anal Chem. 2010;82:9543-8.
29. Mock DM. Rayon balls and disposable-diaper material selectively adsorb creatinine. Am J Clin Nutr. 1992;55:326-30.
30. Stratton SL, Bogusiewicz A, Mock MM, Mock NI, Wells AM, Mock DM. Lymphocyte propionyl-CoA carboxylase and its activation by biotin are sensitive indicators of marginal biotin deficiency in humans. Am J Clin Nutr. 2006;84:384-8.
31. Stratton SL, Horvath TD, Bogusiewicz A, Matthews NI, Henrich CL, SpencerHJ, Moran JH,MockDM. Urinary excretion of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. J Nutr. 2011;141:353-8.